Morgens Waterfall Vintiadis & CO Inc Abb Vie Inc. Transaction History

Morgens Waterfall Vintiadis & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $242,891 - $299,551	-3,120 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $277,399 - $308,380	3,120 New	3,120 $295,000
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $1.25 Million - $1.48 Million	-13,965 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $763,683 - $1.02 Million	8,300 Added 146.51%	13,965 $1.32 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $507,357 - $556,359	5,665	5,665 $548,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $306B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Morgens Waterfall Vintiadis & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Morgens Waterfall Vintiadis & CO Inc with notifications on news.